Evidence map›Paper›PMID 35699953›Full record

Trial reportHuman vaccines & immunotherapeutics2022

Ross Shegog, Lara S Savas, C Mary Healy, Erica L Frost, Sharon P Coan, Efrat K Gabay, Sharice M Preston, Stanley W Spinner, Mathew Wilbur, Elisabeth Becker and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ross ShegogDepartment of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.
Lara S SavasDepartment of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.
C Mary HealyDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Erica L FrostDepartment of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.
Sharon P CoanDepartment of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.
Efrat K GabayDepartment of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.
Sharice M PrestonDepartment of Behavioral Sciences, UTHealth School of Public Health, Dallas, TX, USA.
Stanley W SpinnerDepartment of Pediatrics, Texas Children's Pediatrics, Houston, TX, USA.
Mathew WilburDepartment of Pediatrics, Texas Children's Pediatrics, Houston, TX, USA.
Elisabeth BeckerDepartment of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.
Travis TeagueDepartment of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.
Sally W VernonDepartment of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

Funding

Cancer Prevention and Control Research Training and Career Development ProgramT32CA057712 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Bijal A. Balasubramanian, Maria Eulalia Fernandez · 2018 to 2026
$3.2M
NCI NIH HHS T32 CA057712
6 · The paper itself

Abstract

Parent hesitancy contributes to reduced HPV vaccination rates. The HPVcancerfree app (HPVCF) was designed to assist parents in making evidence-based decisions regarding HPV vaccination. This study examined if parents of vaccine-eligible youth (11-12 yrs.) who use HPVCF in addition to usual care demonstrate significantly more positive intentions and attitudes toward HPV vaccination and greater HPV vaccination rates compared to those not using HPVCF. Clinics (n = 51) within a large urban pediatric network were randomly assigned to treatment (HPVCF + usual care) or comparison (usual care only) conditions in a RCT conducted between September 2017 and February 2019. Parents completed baseline and 5-month follow-up surveys. Participant-level analysis determined 1) change in HPV vaccination initiation behavior and related psychosocial determinants and 2) predictors of HPV vaccine initiation. Parents (n = 375) who completed baseline and 5-month follow-up surveys were female (95.2%), 40.8 (±5.8) yrs. married (83.7%), employed (68.3%), college educated (61.9%), and privately insured (76.5%). Between-group analysis of HPVCF efficacy demonstrated that parents assigned to receive HPVCF significantly increased knowledge about HPV and HPV vaccination (

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesAdolescentChildFemaleHealth Knowledge, Attitudes, PracticeHumansMaleParentsPatient Acceptance of Health CareVaccinationPapillomavirus VaccinesHPV vaccinationintervention testingmHealthpatient educationpediatricsRCTvaccine hesitancy

Identifiers

PMID35699953
PMCPMC9621032

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.